Wednesday, July 29, 2015| Latest E-book
You are here:
Novartis
#

Novartis

Articles

Natco Pharma gains 4.5% after filing ANDA with USFDA

Feb 10, 2015

Natco Pharma gains 4.5% after filing ANDA with USFDA

Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer. #India #US #Generic drug #generic drug makers #Sanofi #Natco Pharma #Novartis #Jevtana #ANDA #Cabazitaxel #Fingolimod #Gilenya
Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drug

Jan 14, 2015

Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drug

Cipla, India's fourth-largest generic drugmaker by revenue, had launched its copy of Onbrez in New Delhi in October last year at a fifth of the original drug's price, citing urgent unmet need in India. #India #NewsTracker #Delhi High Court #Cipla #Novartis #respiratory drug #Onbrez
To the brink and back: Key business events in 2013

Dec 31, 2013

To the brink and back: Key business events in 2013

The RBI starting the year off with rate cuts and then reversing its stance on concerns about widening current account deficit. Fears that the US Federal Reserve will start cutting its bond purchase programme sooner than expected only added to the worries. Foreign funds pulled out of the Indian equities and debt in hoards. #Infosys #Inflation #Gold #P. Chidambaram #RBI #Rupee #Ben Bernanke #Phaneesh Murthy #Narayana Murthy #WPI #US Federal Reserve #Raghuram Rajan #Tesco #Ambani #Pepsi #iGate #CPI #CAD #Jignesh Shah #Novartis #NSEL #taper #Tata Trent #RearView2013
Pharma sector registers single digit growth in 2013; regulators increase scrutiny

Dec 29, 2013

Pharma sector registers single digit growth in 2013; regulators increase scrutiny

The Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers. #FDI #Cipla #Sun Pharmaceuticals #Wockhardt #Ranbaxy #Pharma #Torrent Pharmaceuticals #WTO #Biocon #gsk #Pfizer #Piramal Enterprises #USFDA #Novartis #Dr. Reddy #RearView2013 #Elder #IPAB #Zydus #Cadilla
EU fines Ranbaxy, 8 others for blocking cheaper drugs

Jun 20, 2013

EU fines Ranbaxy, 8 others for blocking cheaper drugs

The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. #BreakingNow #Drugs #EU #Ranbaxy #Healthcare #Novartis
Obama tries to fix US patent system by gunning for 'patent trolls'

Jun 05, 2013

Obama tries to fix US patent system by gunning for 'patent trolls'

The Obama administration announced a set of executive orders and policy reforms on Tuesday designed to deal with "patent trolls." Trolls employ no engineers and produce no products. Instead, they amass patents and focus on constant litigation. #Barack Obama #PatentWars #Novartis #Patent Trolls #Technology Patents #Gleevec
Cancer immunotherapy drugs will soon be a $35 bn global industry

May 22, 2013

Cancer immunotherapy drugs will soon be a $35 bn global industry

A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. #Business #ThisisNext #science #Health #Citigroup #Cancer #GlaxoSmithKline #Merck & Co. #AstraZeneca #Novartis #Sector Spotlight #Immunotherapy drugs #Amgen
Novartis patent row: US 'concerned' over India's patent norms, innovation

May 02, 2013

Novartis patent row: US 'concerned' over India's patent norms, innovation

Raising questions over innovation climate in India, the US has said the recent decision by India's Supreme Court to prohibit patent of Novartis' cancer drug Glivec could "preclude issuance of a patent" in the country. #India #WhyNow #Drugs #Innovation #Patent #Pharma #Novartis #glivec
US lawsuit accuses Novartis of health care fraud

Apr 24, 2013

US lawsuit accuses Novartis of health care fraud

The US government has sued Novartis Pharmaceuticals, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own. #CompanyWatch #law suit #Novartis #Healthcare violation